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AbstrACt 
Objectives Depression has been reported to be a risk 
factor of cardiovascular disease in the western world, but 
the association has not yet been studied among Asian 
populations. The aim of this study was to investigate 
whether depression increases the risk of developing 
atherosclerotic cardiovascular disease (ASCVD) in a large 
Korean cohort study.
Design Population based cohort study.
setting Database of National Health Insurance System, 
Republic of Korea.
Participants 481 355 Koreans (260 695 men and 220 660 
women) aged 40–80 years who had a biennial health 
check-up between 2002 and 2005.
Main outcome measure The main outcome in this study 
was the first ASCVD event (hospital admission or death).
results Depression increased the risk of developing 
ASCVD by 41% for men and 48% for women. In men, 
3–4 outpatient visits for depression increased the risk of 
angina pectoris by 2.12 times (95% CI 1.55 to 2.90) and 
acute myocardial infarction by 2.29 times (95% CI 1.33 to 
3.95). Depression was also associated with stroke in men 
(HR 1.29, 95% CI 1.19 to 1.39) and in women (HR 1.37, 
95% CI 1.29 to 1.46). However, no increased risk of ASCVD 
was found for men who received 10 or more depressive 
treatments, compared with those without any outpatient 
visit for depression.
Conclusions In this cohort, depressed people were at 
increased risk of ASCVD incidence. Therefore, individuals 
with depression may need routine monitoring of heart 
health that may prevent their future CVD risk.
IntrODuCtIOn
Depression or depressive symptoms have been 
linked to increased cardiovascular disease 
(CVD), including coronary heart disease and 
stroke.1–4 A growing body of evidence suggests 
that the impact of depressive symptoms on 
CVD may differ by race, with depressive symp-
toms conferring an elevated risk for CVD in 
African-Americans, compared with whites.5 6 
However, less is known about the experiences 
of people from Asian countries.
Depression is an increasingly common 
illness in Korea, with a gradual increase in the 
prevalence of depression over the past decade 
(2001, 4.3%; 2011, 6.7%).7 8 This might be 
due to the fact that Korea has undergone 
unprecedented economic growth and faced 
multiple changes since 2000. In fact, Korea 
has the second highest suicide rate among 
developed countries.9 Despite the potential 
relevance of depression as a risk factor for 
CVD risk in Korean population, few studies 
have examined the association between 
depression and important clinical endpoints, 
such as CVD mortality.
The importance of psychosocial factors of 
CVD risk among persons with low socioeco-
nomic status (SES) has also been increas-
ingly appreciated.10–12 In the Reasons for 
Geographic and Racial Differences in Stroke 
study, participants with both depressive symp-
toms and stress had the greatest risk of inci-
dent CVD events and death only for those 
with low income (<$35 000) and not with 
higher income.12
Using data from a large-scale cohort study, 
we examined whether depression increases 
the risk of atherosclerotic CVD (ASCVD) 
independently of existing cardiac risk factors. 
We also assessed whether SES modifies the 
association between depression and ASCVD 
risk.
strengths and limitations of this study
 ► Depression was defined as the presence of objective 
data such as outpatient visit and antidepressant pre-
scription rather than categorisation by self-reported 
questionnaire scores.
 ► The usage of mean value of multiple measurements 
allowed us to minimise measurement error of expo-
sure variables.
 ► This prospective study is the virtually complete fol-
low-up for fatal and non-fatal events identified from 
national insurance claims.
 ► Since non-fatal events are insurance claim data, 
their accuracy has been controversial.
 ► Findings of this study may not be generalisable to 
other ethnic groups.
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study Population
The study population is a representative sub-sample 
of subjects who undertook national health screening 
programme provided by National Health Insurance 
System (NHIS). NHIS has provided repeat health screen-
ings every 2 years to 500 000 people who received health 
screenings between 2002 and 2003. Among these 500 000, 
the study selected 481 355 participants who were repeat-
edly screened between 2004 and 2005. Participants were 
excluded from the analyses if they had a record of admis-
sion or outpatient for CVD from 2002 to 2005. Hospital 
diagnoses were reported to the study and coded to the 
WHO’s International Classification of Diseases, 10th Revi-
sion (ICD-10) (WHO, 1992).
Measurement variables
Height and body weight were measured as anthropo-
metric variables. Body mass index (BMI) was calculated 
by dividing body weight (kg) by the square of height 
(m). Blood pressure was measured by a trained techni-
cian using an automatic sphygmomanometer or mercury 
sphygmomanometer. All those who participated in the 
national health screening provided by NHIS were asked 
to be fasted until the morning after dinner the previous 
day. The variables measured through fasting blood were 
total cholesterol, blood glucose and liver function tests. 
For those who had multiple measurements for the same 
continuous variables, we used their mean measurement 
to reduce measurement error. Each health examination 
centre had internal and external quality control proce-
dures directed by the Korean Association of Laboratory 
Quality Control. Agreement for each biomedical marker 
across individual hospital was high (correlations coeffi-
cients range 0.96–0.99).13
Participants completed a questionnaire that included 
questions on their health status and life style factors 
such as smoking status, alcohol drinking and exer-
cise. We examined smoking status using the first survey 
data, or where there was missing in the first survey, the 
second survey data. In this study, medical premiums were 
regarded as a proxy for SES because, in Korea, medical 
insurance premiums are given in proportion to social and 
economic levels. Depression was defined as the hospital 
outpatient use and diagnosis of depression (ICD-10 codes 
F32-F33) or history of medication for depression.
Assessment of depression
Participants were classified as depressed if they had at 
least one outpatient visit due to depression (ICD-10 
codes F32-F33) or were prescribed depression medica-
tion at more than three visits. Between 2002 and 2005, 
13 antidepressants were listed in the medication database 
at the health insurance review and assessment service: 
the medications included sertraline, paroxetine, fluvox-
amine, citalopram, mirtazapine, trazodone, phenelzine 
imipramine, amitriptyline, nortriptyline, amoxapine, 
lofrepramine and tianeptine.
Outcomes
We defined incident ASCVD as the first hospital admis-
sion with a diagnosis of ASCVD (ICD-10 codes), or, where 
there was no relevant hospital admission, death due to 
ASCVD as the underlying cause (ICD-10 codes). The 
detailed outcomes used in this study include ischaemic 
heart disease (IHD) (ICD-10 codes I20-I25), stroke 
(ICD-10 codes I60-I69) and other CVD (ICD-10 I10-I15, 
I70-I74, R96, I50, I51, I44-I49). IHD was further divided 
into angina pectoris and acute myocardial infarction. 
Stroke was divided into ischaemic and haemorrhagic 
stroke.
All ASCVD events or detailed outcome data for hospital 
records were available from NHIS for participants at base-
line (2002–2005) from 1 January 2006 to 31 December 
2013. Information on causes of death for the participants 
was confirmed by the National Statistical Office.
A validation study was conducted in collaboration with 
the Korean Society of Cardiology through the formation 
of the Event Validation Committee (July 2008–May 2009). 
For participants who provided written permission for the 
use of their personal information, 673 coronary heart 
disease events between 1994 and 2007 were confirmed 
with individual hospital medical records, and 73% of the 
cases of myocardial infarction were validated.14 Another 
study reported that 83% of stroke diagnoses were vali-
dated among a sample of 626 stroke patients.15
statistical analysis
First, descriptive analyses of distribution of depression 
by general characteristics and cardiac risk factors were 
conducted in men and women.
Second, the age-adjusted incidence rate of ASCVD per 
100 000 person-years was calculated by the number of 
outpatient visits due to depression (None, 1–2, 3–4, 5–9 
and 10 or more). The incidence rate was standardised 
to the age distribution of Korean national population in 
2000.
Third, Cox regression models were used to estimate 
hazard ratios (HRs) and the 95% cCIs. The indepen-
dent effects of depression on ASCVD were analysed by 
adjusting for known risk factors for ASCVD: age, smoking 
status, hypertension, hypercholesterolaemia, diabetes 
and chronic renal failure. We also evaluated the propor-
tional hazards assumption based on Schoenfeld residuals 
test. In order to avoid reverse causation bias attribut-
able to underlying diseases, we analysed the events after 
excluding the first 2 years of follow-up.
Lastly, we investigated the effect of the interaction 
between depression and SES on the development of 
ASCVD events. Participants were classified into six groups 
reflecting psychosocial risk at baseline: (1) no depression 
and high SES, (2) no depression and middle SES, (3) no 
depression and low SES, (4) depression and high SES, (5) 
depression and middle SES and (6) depression and low 
SES. Analyses were conducted using SAS software V.9.4 
(SAS institute).
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Patient and public involvement
Neither patients nor members of the public were involved 
in this study.
results
General characteristics
Table 1 summarises the characteristics of the study popu-
lation at baseline by sex and depression. In this study, 
4.9% of males and 10.0% of females had at least one 
outpatient visit for depression during baseline years or 
were prescribed depression medication at more than 
three visits (table 1). The majority of participants (96.9%) 
had no outpatient visit. The most frequent outpatient visit 
was 1–2 times (1.64%), followed by 3–4 times (0.43%), 
5–9 times (0.42%) and at least 10 and more visits (0.61%) 
(data not shown).
The overall mean age was 52.8 years (52.0 years for 
men and 53.7 years for women). The mean age of the 
participants with depression was higher in both men and 
women than that of those with no depression. The mean 
BMI was 24.0 kg/m2 for both men and women. There 
was no difference in BMI by depression status. The levels 
of systolic blood pressure, diastolic blood pressure and 
fasting blood glucose were higher in men, whereas women 
had higher total cholesterol levels than men. In men and 
women, the prevalence of diabetes mellitus was higher in 
those with depression. The overall current smoking rate 
was 24.2% (42.4% for men and 2.8% for women).
Depression and AsCVD risk
During a median follow-up of 8 years (3 557 303 person 
years), 40 813 ASCVD (5570 fatal), 16 915 IHD (1645 
fatal) and 17 846 stroke (2584 fatal) occurred. Partici-
pants with depression at baseline had a higher risk of 
developing heart disease during the 8-year follow-up 
period (see online supplementary figures 1 and 2) than 
those with no depression. Table 2 shows the risk of devel-
oping ASCVD by the number of depression outpatient 
use in men. Overall, the risk of ASCVD was 41% higher 
among men with at least one outpatient visit for depres-
sion compared with those with no outpatient visit at base-
line (HR=1.41; 95% CI 1.34 to 1.48). The risk of ASCVD 
increased with increasing number of outpatient visits but 
not for those with ≥10 visits. In particular, 3–4 outpatient 
visits for depression had the strongest effects on devel-
oping angina pectoris (HR=2.12; 95% CI 1.55 to 2.90) 
and acute myocardial infarction (HR=2.29; 95% CI 1.33 
to 3.95), compared with no visit history. Similar to the 
overall ASCVD, the risk of developing angina pectoris 
was lower (but still significant) in participants who had 
10 or more visits for depression, compared with those 
who had nine or less visits. While there was no association 
of depression with haemorrhagic stroke, the association 
appeared to be significant with total stroke (HR=1.29; 
95% CI 1.19 to 1.39) and ischaemic stroke (HR=1.05; 
95% CI 1.03 to 1.07).
Table 3 shows the results for women. The overall results 
were similar to those of men. The overall risks of total 
stroke or ischaemic stroke were significantly higher in 
Table 1 General characteristics of study participants at baseline (2002–2005)
N (%)
Total Men (n=260 695) Women (n=220 660)
481 355
No depression Depression* No depression Depression*
247 844 (95.1) 12 851 (4.9) 198 581 (90.0) 22 079 (10.0)
Age, year 52.8 (9.6) 51.8 (9.3) 56.4 (10.2) 53.3 (9.7) 57.1 (9.8)
Body mass index, kg/m2 23.9 (2.9) 24.0 (2.8) 23.7 (2.9) 23.9 (3.0) 24.2 (3.1)
Systolic BP, mm Hg 126.8 (16.5) 128.4 (15.7) 128.5 (15.9) 124.8 (17.2) 126.6 (17.3)
Diastolic BP, mm Hg 79.4 (10.5) 81.0 (10.1) 80.4 (10.0) 77.4 (10.6) 78.1 (10.5)
Total cholesterol, mg/dL 199.5 (35.1) 197.5 (34.4) 196.2 (35.0) 201.6 (35.7) 205.5 (36.8)
Fasting glucose, mg/dL 98.1 (28.1) 99.9 (29.3) 103.8 (37.1) 95.3 (24.9) 99.3 (31.5)
Hypertension, % 27.7 30.3 30.8 24.2 27.1
Diabetes, % 7.5 8.7 12.1 5.6 8.8
High cholesterol, % 12.3 10.8 10.6 13.8 16.4
Chronic renal failure, % 0.24 0.26 0.52 0.19 0.33
Cigarette smoking, %
Ex 8.9 15.6 15.7 0.9 1.0
Current 24.2 42.5 36.8 2.7 3.5
Values are mean (SD).
*Depression was defined as a patient who had at least one outpatient visit for depression or were prescribed depression medication at more 
than three visits.
BP, blood pressure.
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depressed patients. Likewise, there was no association 
with haemorrhagic stroke.
Depression and AsCVD risk by ses
Figure 1 shows how medical insurance premium as a surro-
gate for SES modifies the association between depression 
and the risk of developing ASCVD in men and women. 
For men with low (bottom tertile) or high (top tertile) 
SES, the risk of ASCVD increased with increasing number 
of outpatient visits but flattened. In these SES groups, the 
ASCVD risk did not reach statistical significance when 
the number of outpatient visits was 10 or more. Women 
who had at least one outpatient visit were at high risk of 
ASCVD in all SES groups. Figure 2 shows combination 
effects of depression and SES at baseline on the devel-
opment of heart disease. In men, depression-free group 
had a reduced survival in low SES group, while depressed 
group showed a reduced survival in middle or low SES 
group. Depressed women showed a reduced survival, 
regardless of their SES at baseline.
DIsCussIOn
The study found that depression in general population 
of Korea increased the risk of ASCVD with about 40%. In 
men, depression increased the risk of angina pectoris and 
acute myocardial infarction by up to twofold. However, 
even if participants had depression at baseline, the risk of 
developing ASCVD was not increased as long as they had 
at least 10 outpatient visits for depression. This finding 
was similarly observed in low or high SES group in men. 
However, the risk of ASCVD was high in women with 
depression in all SES groups.
Overall, the results of this study were consistent with 
previous studies. The main finding of our study was 
that the risk of heart disease was not increased when 
men received 10 or more depressive treatments during 
the follow-up periods. In women, however, the risk of 
ASCVD was high in those with depression, regardless of 
the number of visits or SES levels. A possible explana-
tion for this finding is that most women in the study were 
postmenopausal women (with mean age of 52.8 years at 
baseline) who were at increased risk of CVD. The results 
Figure 1 Depression treatment frequency and atherosclerotic cardiovascular disease risks according to socioeconomic level. 
The socioeconomic level is divided into three levels according to the level of medical insurance premiums.
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suggest that the risk of ASCVD may not be modified by 
the number of outpatients or SES levels in depressed 
middle-aged women.
Depression has been linked with various behavioural 
risk factors such as smoking, obesity, diabetes and meta-
bolic syndrome.16 17 A comprehensive review concluded 
that obesity, hyperlipidaemia, hypertension and diabetes 
are now perceived as important comorbid conditions in 
depressed patients.18 It is also known that patients with 
depression are less likely to adhere to medical recom-
mendations, contributing to poor health outcomes.19 20 
In addition, depressed people have maladaptive coping 
style, social isolation and chronic life stress.21–23
The mechanisms underlying the association between 
depression and cardiovascular risk remain poorly under-
stood. Increased platelet reactivity has been associated in 
cross-sectional studies.24 A cross-sectional study revealed 
that depression and anxiety enhanced platelet aggrega-
tion, which can cause recurrent acute coronary syndrome 
in secondary prevention.25 Further research is needed to 
determine whether depression directly increases these 
cardiovascular events or whether this association is medi-
ated by the risk factors of CVD, such as elevated blood 
pressure, cholesterol or blood glucose.
In our study, only 4.9% of males and 10.0% of females 
visited outpatients for depression during baseline period 
Figure 2 Probability of atherosclerotic cardiovascular disease event-free survival according to depression and socioeconomic 
level. The socioeconomic level is divided into three levels according to the level of medical insurance premiums. SES, 
socioeconomic status.
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(2002–2005). Similarly, the prevalence of depression with 
Patient Health Questionnaire 9 was 4.2% for males and 
9.1% for females according to the Nationally Representa-
tive Survey of Korea National Health and Nutrition Exam-
ination Survey.25 26 The prevalence of depression is low 
in Korea, and even if people are aware of their depres-
sion, the actual rate of treatment is likely to be very low. 
Moreover, the rate of continuing treatment of depres-
sion is expected to be even lower. We therefore suggest 
that regular outpatient visits may serve as a basis for the 
prevention of the risk of developing ASCVD. Further 
studies are needed to verify the true association between 
depression and ASCVD with long-term follow-up.
The main strength of this prospective study is the virtu-
ally complete follow-up for diseases and deaths in a large 
study population. Moreover, the usage of mean value of 
multiple measurements allowed us to minimise measure-
ment error of exposure variables. Another strength of this 
study is the presence of objective data such as outpatient 
visit and antidepressant prescription for defining depres-
sion rather than categorisation by self-reported question-
naire scores.
Nonetheless, this study has some limitations. In this 
study, events of CVD were confirmed by NHIS hospital-
isation data. Since these data are insurance claim data, 
their accuracy has been controversial. We have conducted 
two studies on the validity of the data for heart disease 
and stroke. According to previous validation studies, the 
validity of acute myocardial infarction was higher than 
90%, and that of stroke was 83%.14 15 However, validity 
study of angina has not yet been reported. Therefore, we 
believe that classification errors for the outcome may still 
exist. In general, if classification errors exist, the associa-
tion of exposure variables and outcomes tends to toward 
the null. In this study, whether the weak association with 
stroke was genuinely relevant or due to classification 
errors should be carefully examined. Another limitation 
of our study is that the number of visits with depression 
ICD-10 code is being used as a proxy for severity of depres-
sion. In fact, more visits could actually mean better treated 
depression, which may be why greater than 10 or more 
outpatient visits does not correspond to increased ASCVD 
risk in our study. On the other hand, the lack of increased 
risk may indicate proper treatment of depression reduces 
ASCVD risk, and 10 or more visits for depression is a surro-
gate endpoint of treatment compliance, of attending the 
follow-up visits with their doctor and in general of proper 
mental treatment. However, further studies with longer 
term follow-up should be conducted to elucidate an exact 
endpoint of proper mental treatment.
COnClusIOns
In this large Korean cohort, depression increased the risk 
of ASCVD incidence by around 40%. Therefore, men and 
women with depression may need routine monitoring of 
heart health that may prevent their future CVD risk.
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